Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
06/2012
06/28/2012CA2822493A1 Selective glycosidase inhibitors and uses thereof
06/28/2012CA2820448A1 2-amino-4-arylthiazole compounds as trpa1 antagonists
06/27/2012EP2468752A1 Thiazolopyridine derivatives as sirtuin-modulators
06/27/2012EP2468717A1 Heterocyclic Amide Compounds Useful as Kinase Inhibitors
06/27/2012EP2150251B1 Thienopyridine and thiazolopyridine derivatives that inhibit prolyl hydroxylase activity
06/27/2012EP2007729B1 Substituted tetrahydroisoquinoline compounds, their preparation and use in medicaments
06/27/2012CN102516240A Heteroaryl-ureas and their use as glucokinase activators
06/27/2012CN102516155A 2-alkoxy-4-halo-6-alkylphenyl-substituted (hetero)cyclic ketoenols
06/27/2012CN101563353B Antibacterial compounds and processes for its production
06/26/2012US8207348 Thiazolothiazole compound and thiazolothiazole polymer
06/26/2012US8207158 5HT2c receptor modulators
06/26/2012CA2511970C Urea derivatives useful in the treatment of heart failure
06/21/2012WO2012082633A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/21/2012WO2012081563A1 Benzothiazole and azabenzothiazole derivative having endothelial lipase inhibitory activity
06/21/2012WO2012080456A1 Bicyclic ring system substituted amide functionalised phenols as medicaments
06/21/2012US20120157658 Methods, compositions, and apparatuses for forming macrocyclic compounds
06/21/2012US20120157448 Compounds for treating neurodegenerative diseases
06/21/2012US20120157439 Raf inhibitor compounds and methods of use thereof
06/21/2012CA2822044A1 Novel 1,2- bis-sulfonamide derivatives as chemokine receptor modulators
06/19/2012US8203001 Chemical compounds
06/19/2012US8202861 Compositions useful as inhibitors of voltage-gated sodium channels
06/19/2012US8202858 Vasopressin V1a antagonists
06/19/2012CA2613303C An oxime derivative for use as a glucokinase activator
06/14/2012WO2012078859A2 Protein kinase d inhibitors
06/14/2012WO2012076966A1 Substituted thieno [3,4-b] pyrazine compounds
06/14/2012WO2012076942A1 4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
06/14/2012US20120149676 Novel compounds
06/14/2012US20120149573 Herbicidal bus-nitrogen-containing oxo and sulfono heterocycles
06/13/2012EP2462142A1 Metabotropic glutamate receptor modulators
06/13/2012EP1626051B1 Crystals of quinolinecarboxylic acid derivative solvate
06/13/2012CN102498091A Glycine compound
06/13/2012CN102002059B Process for producing thiazole derivative
06/13/2012CN101611038B 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
06/13/2012CN101208334B Novel cyclic amines
06/13/2012CN101014598B Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/12/2012US8198483 Phenethanolamine derivatives for treatment of respiratory diseases
06/12/2012US8198454 Amide derivatives and medicinal use thereof
06/12/2012US8198299 Cycloalkylidene and heterocycloalkylidene inhibitor compounds
06/12/2012US8198269 Fused aminodihydrothiazine derivative
06/12/2012CA2647596C Pyrrolo- and thiazolo-pyridine compounds as hif modulators
06/07/2012WO2012074180A1 Novel tetraazacyclododecan-tetraone derivative or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same for preventing or treating cancer
06/07/2012WO2012072019A1 Targeting human thymidylate kinase induces dna repair toxicity in malignant tumor cells
06/07/2012WO2012023145A3 Prasugrel hydrochloride crystalline particles
06/06/2012EP2459560A1 Ring-annulated dihydropyrrolo[2,l-a]isoquinolines
05/2012
05/31/2012WO2012071519A1 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
05/31/2012WO2012071511A1 Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
05/31/2012WO2012071458A1 Heterocyclic inhibitors of beta - secretase for the treatment of neurodegenerative diseases
05/31/2012WO2012070582A1 Conjugated compound, and organic thin film and organic thin film element using same
05/31/2012WO2012069633A1 Microbicidal heterocycles
05/31/2012US20120135982 5HT2c RECEPTOR MODULATORS
05/31/2012US20120135980 Gamma secretase modulators
05/31/2012CA2818889A1 Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
05/31/2012CA2818885A1 Benzoxazepines as inhibitors of mtor and methods of their use and manufacture
05/30/2012EP2457901A1 Benzazole derivatives, compositions, and methods of use as B-secretase inhibitors
05/30/2012EP2457896A1 Tripeptides as caspase modulators
05/30/2012EP2457895A1 Tetrapeptide analogs
05/30/2012EP2456754A1 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway
05/30/2012CN1993367B Condensed pyrimidine derivative and xanthine oxidase inhibitor
05/30/2012CN102482278A Pyrimidinones as PI3K inhibitors
05/30/2012CN102481296A 溶解性改善的药用组合物 Improved solubility of the pharmaceutical composition
05/30/2012CN101429200B Tricyclic benzopyran compound as anti-arrhythmic agents
05/30/2012CN101360748B Inhibitors of c-met and uses thereof
05/29/2012US8188282 Regioselective palladium catalyzed synthesis of benzimidazoles and azabenzimidazoles
05/29/2012US8188115 5-HT7 receptor antagonists
05/29/2012CA2483998C Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
05/29/2012CA2463966C Pyrazolyl-substituted heterocycles and their use as phytosanitary products
05/24/2012WO2012068234A2 Antiviral compounds
05/24/2012WO2012068211A1 Tricyclic inhibitors of pro-matrix metalloproteinase activation
05/24/2012US20120129846 Gamma secretase modulators
05/24/2012US20120129811 Tricyclic inhibitors of pro-matrix metalloproteinase activation
05/24/2012CA2818389A1 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
05/24/2012CA2817840A1 Antiviral compounds
05/23/2012CN102471602A Materials for organic electroluminescence devices
05/23/2012CN102471351A 用作pi3k抑制剂的2-羧酰胺环氨基脲 Used as pi3k inhibitor 2- carboxamide ring semicarbazide
05/23/2012CN102471334A 促代谢型谷氨酸受体调节剂 Metabotropic glutamate receptor modulators
05/23/2012CN102471296A Bace抑制剂 Bace Inhibitors
05/23/2012CN101899058B Method for preparing thiazolopyrimidine compound, thiazolopyrimidine compound and application thereof
05/23/2012CN101838238B Method for synthesizing quinolone main cycle compound
05/22/2012US8183241 2-oxo-1-pyrrolidine derivatives
05/18/2012WO2012064973A2 Heterocyclic compounds and uses thereof
05/18/2012WO2012062157A1 Pyrano[3,2-d]thiazol derivatives and uses thereof as selective glycosidase inhibitors
05/18/2012WO2012061972A1 Selective glycosidase inhibitors and uses thereof
05/18/2012WO2012061971A1 Selective glycosidase inhibitors and uses thereof
05/18/2012WO2012061927A1 Selective glycosidase inhibitors and uses thereof
05/18/2012CA2817577A1 Heterocyclic compounds and uses thereof
05/17/2012US20120122918 Antibacterial agents
05/17/2012US20120122838 Heterocyclic compounds and uses thereof
05/17/2012US20120122835 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
05/17/2012US20120122804 Substituted quinobenzoxazine analogs
05/17/2012US20120122680 Mesoionic pesticides
05/17/2012US20120122679 Mesoionic pesticides
05/16/2012EP2451811A1 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
05/16/2012EP2451793A1 Bace inhibitors
05/16/2012EP1934233B1 Sulfonamide derivatives as glycokinase activators useful in the treatment of type 2 diabetes
05/16/2012CN102459283A C-met 蛋白激酶的氨基吡唑三唑并噻二唑抑制剂 C-met protein kinase aminopyrazole triazolo thiadiazole inhibitor
05/16/2012CN102459282A 作为pi3-激酶抑制剂用于治疗癌症的硫杂-三氮杂-环戊二烯并薁 Sulfur as pi3- kinase inhibitors for the treatment of cancer hetero - triaza - cyclopenta azulene
05/16/2012CN102459281A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
05/16/2012CN102459272A 对P110δ具有选择性的为PI3K抑制剂的二环嘧啶化合物和使用方法 Selective for P110δ bicyclic pyrimidine compounds and methods of use for the PI3K inhibitor
05/16/2012CN102459265A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
05/16/2012CN102459264A 激酶活性的嘧啶抑制剂 Pyrimidine inhibitors of kinase activity
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 ... 152